INFLUENCE OF TILE SECRETOR AND LEWIS
In all series so far published it has been found that people of blood group 0 and non-secretors of the ABO blood-group substances suffer from duodenal ulcer more often than the rest of the population (Doll et at., 1961) . This paper describes an attempt to define the way in which non-secretion affects susceptibility to duodenal ulcer.
The secretor gene has no known direct expression, but exerts its effects on the composition of the mucous secretions of the body by interaction with the ABO and Lewis genes, all three genes being inherited independently of each other. The saliva of all secretors contains H antigen, and that of blood group A, B, and AB secretors A, B, or both; the saliva of non-secretors lacks ABO specificity. The relationship between the secretor and Lewis genes is less well understood. The simplest explanation of the known facts is that possession of the Lewis gene, which confers the ability to synthesize Lea substance, a mucopolysaccharide closely related to the ABO blood-group substances, is inherited as a dominant character. The saliva of people who are genetically capable of synthesizing Lea substance usually contains very much more of the substance if they are ABO non-secretors (with the red-cell phenotype Le(a + b -)) than if they are secretors (red-cell phenotype Le(a -b +)), perhaps because in secretors the ABO gene has priority in determining the chemical nature of a limited available quantity of water-soluble mucopolysaccharide (Race and Sanger, 1959 Le(a+b-) persons were more susceptible to duodenal ulcer than Le(a-b+) or Le(a-b-) persons.
In the first two cases the Lewis gene system will not be involved, and the relative numbers of subjects with and without the Lewis gene will be the same among patients with duodenal ulcer as in the general population. In the third case any excess of non-secretors should be made up entirely of Le(a+b-) subjects, and there should be both relatively and absolutely fewer non-secretors who are Le(a-b-) (Doll et al., 1961) , and too few women were seen to justify separate comparison. The following controls were used:
(1) 26.027 Yoruba blood donors who have attended the blood transfusion department at the hospital.
(2) 300 male Yoruba subjects. These men were patients or their relatives attending the main reception clinic of the hospital, at which nearly all the patients with duodenal ulcer had initially been seen. None of them complained of symptoms suggesting that they might have a duodenal ulcer. Their secretor status was determined, and the Lewis phenotype of all nonsecretors and of 75 secretors.
Methods
The ABO groups were determined by a standard tube technique.
Secretor status was determined by the effect of undiluted saliva in inhibiting agglutination by Ulex extract (anti-H), and anti-A and anti-B grouping sera. All the samples were tested for the presence of H antigen; the saliva of all the controls, and of patients who were not of group 0, was also tested for A and B.
The Lewis group was determined from the saliva. The presence of Lea substance was detected by its action in inhibiting the effect of lytic anti-Lea sera on papainized cells. Samples of saliva were heated for 15 minutes in a boiling-water bath within one hour of collection and stored at -20°C. They were centrifuged immediately before use. Two volumes of a 1 in 12 solution of L6w's papain in phosphate buffer (pH 7.3) and one volume of group 0 Le(a + b -) red cells were incubated at 370 C. for 15 minutes; the cells were washed, and were used on the same day. One drop of antiserum was added to one drop of diluted saliva, and after 15 minutes at room temperature one drop of 5% papainized cells was added. The tubes were incubated at 37°C. for between half and one hour and the results read without centrifuging. The antiserum always caused complete haemolysis when diluted 1: 2 with saline, and inhibition was recorded as being present only if no visible haemolysis had occurred.
Secretor saliva was tested at a dilution of 1: 5 and 1:10. Non-secretor saliva was tested at 1: 5, 1: 10, 1:20, 1: 100, 1:200, and 1: 1,000. Antiserum from the same donor was used to test all the non-secretor samples, but secretor saliva was tested with one or more of three different antisera. Many samples of non-secretor saliva were also checked against all three antisera; although the inhibitory titre sometimes varied, the apparent Lewis group was always the same. Red cells from the same donor were used throughout.
Results

ABO Group
The ABO group of the 172 patients with duodenal ulcer is shown in Table I Secretor Status
The secretor status of the 300 male control subjects is shown in Table III Saliva from ABO secretors was tested at a dilution of 1: 5 and 1:10 only. There were altogether 224 control secretors, of whom 75 were tested.
of ABO non-secretors among the patients with duodenal ulcer was entirely accounted for by the large number of patients who were Le(a + b -). The expected number of Le(a-b-) non-secretors was 17, and only 13 were found. Among secretors, on the other hand, there was no abnormal preponderance of Le(a-b +) over Le(a-b-) patients, and their relative numbers did not differ significantly from the controls (x2'=0.63, n= 1, P>0.3).
It can be seen in Table IV that the saliva of Le(a + b -) patients with duodenal ulcer inhibited the antiserum to a titre of 1:1,000 more often than that of Le(a + b-) controls. Only one sample was tested from each subject, however, and the numbers are too small to justify any conclusion from this difference.
Discussion
These results suggest that the Lewis gene influences susceptibility to duodenal ulcer. People who possess the Lewis gene are apparently only abnormally predisposed to duodenal ulcer when they are also ABO non-secretors. Conversely, absence of the secretor gene appears only to be disadvantageous in subjects who possess the Lewis gene. Clearly this work needs to be repeated elsewhere, and no confidence can be placed in a single study. If the results are confirmed, however, they suggest that susceptibility to duodenal ulcer is not affected by either the secretor or Lewis genes acting alone, but by their interaction.
The relative frequencies of the different Lewis phenotypes in the control subj,ects (Table 111) agree well with those found by Barnicot and Lawler (1953) of their Le(a -) subjects who belonged to group 0 or A were tested with anti-Leb serum, and 45 proved to be Le(a -b +). The distribution of the Lewis phenotypes in patients with duodenal ulcer has previously been studied by Clarke et al. (1956) in Liverpool. A relative deficiency of Le(a-) patients was found among male non-secretors. Among female patients, on the other hand, they found a considerably greater frequency of non-secretors than among men, and more than the expected proportion were Le(a -). There were too few patients of either sex for these differences to be statistically significant.
Secretor status and Lewis group appear to affect the likelihood of a person's developing a duodenal ulcer rather more than does the ABO group. Woolf (1955) showed how the liability to disease of subjects of a particular blood group could best be expressed by comparison with the liability of persons of a blood group thought not to predispose to the disease in question. When Woolf's method is applied to the patients described here, patients of group 0 are found to have suffered from duodenal ulcer 1.43 times more often than patients of groups A, B, and AB combined (with 95%A confidence limits between 1.17 and 1.76).
ABO non-secretors were 1.74 times more liable than secretors (1.16-2.62), and Le(a+b-) subjects were 2.26 times more liable than subjects belonging to the other Lewis phenotypes considered together (950% confidence limits between 1.42 and 3.61).
If susceptibility to duodenal ulcer is affected by interaction of the secretor and Lewis genes in the manner proposed above, it is like-ly that the immediate factor responsible is a difference between Le(a + b-) and other people in the character of their gastrointestinal mucus. Evidence has been pre-sented by Clarke et al. (1959) and by Evans (1960) that the total quantity of mucopolysaccharide carrying blood group specificity is the same in the saliva of secretors and nonsecretors and of patients with and without duodenal ulcer, with the inference that differences in susceptibility to duodenal ulceration do not depend upon differences in the quantity of such mucopolysacch-aride which is available for mucosal defence. It is possible that any difference is qualitative rather than quantitative, and that mucus which is largely Lea-specific is less efficient in this respect than mucus which is not.
Summary
The ABO group has been determined in 390 Nigerians of both sexes with duodenal ulcer, and the secretor status and Lewis group in 172 male patients. There was an excess of people of group 0 and of ABO nonsecretors among these patients by comparison with control subjects drawn from the same tribe.
The excess of non-secretors was entirely made up of patients who were Le(a + b-), and there were fewer than the expected number of Le(a-b-) non-secretors. Among secretors the relative frequencies of Le(a-b+) and Le(a -b -) subjects did not suffer from those found among the controls.
It is suggested that the enhanced liability of ABO non-secretors to duodenal ulcer depends upon the interaction of the secretor and Lewis genes.
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